SCHEMBL31573580

SCHEMBL31573580

OCc1cnc(F)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDXK O00764 2/20 0.41
▸ ALDH1A1 P00352 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CBFB Q13951 1/20 0.32
▸ RECQL P46063 1/20 0.31
▸ CYP11B2 P19099 1/20 0.31
▸ LMNA P02545 2/20 0.31
▸ SUV39H2 Q9H5I1 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ AOX1 Q06278 1/20 0.30
▸ MKNK1 Q9BUB5 1/20 0.30
▸ MKNK2 Q9HBH9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26971010 1.00 PDXK (0.41) PDXKALDH1A1KDM4EHPGDHSD17B10
SCHEMBL7992256 0.81 CYP11B2 (0.32) MAPK1CYP11B2
SCHEMBL18614801 0.80 MAPK1 (0.34) PDXKALDH1A1KDM4EHPGDHSD17B10
SCHEMBL21737250 0.79 NOS3 (0.38) ALDH1A1MAPK1CYP11B2MKNK1MKNK2
SCHEMBL29411201 0.78 PDXK (0.44) PDXKALDH1A1KDM4EHPGDHSD17B10
SCHEMBL992612 0.78 PDXK (0.44) PDXKALDH1A1KDM4EHPGDHSD17B10
SCHEMBL14932548 0.76 ALDH1A1 (0.41) PDXKALDH1A1GAAHTT
SCHEMBL393029 0.75 PDXK (0.33) PDXKALDH1A1KDM4EHPGDHSD17B10
SCHEMBL21722863 0.75 LMNA (0.34) PDXKALDH1A1KDM4EHPGDHSD17B10
SCHEMBL18795074 0.75 ALDH1A1 (0.41) PDXKALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096751-A1 MACROCYCLIC INHIBITORS OF ATP CITRATE LYASE ESPERION THERAPEUTICS, INC. (US) 2025-05-08 — — WO disclosed
Send feedback